Transition from an M1 to a mixed neuroinflammatory phenotype increases amyloid deposition in APP/PS1 transgenic mice

Erica M Weekman, Tiffany L Sudduth, Erin L Abner

  • 1Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA. donna.wilcock@uky.edu.

Abstract

Insights

Inducing an M1 neuroinflammatory phenotype in mice initially reduced amyloid-beta (Aβ) but later transitioned to a mixed phenotype, increasing Aβ burden and disease progression.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Neuroinflammation plays a role in Alzheimer's disease (AD).
  • The long-term impact of specific neuroinflammatory phenotypes on amyloid-beta (Aβ) pathology is not well understood.
  • Previous short-term studies suggest M1 neuroinflammation may reduce Aβ.

Purpose of the Study:

  • To investigate the long-term effects of an M1 neuroinflammatory phenotype on Aβ pathology in a mouse model of AD.
  • To track the transition of neuroinflammatory phenotypes over time and their correlation with Aβ accumulation.

Main Methods:

  • Adeno-associated viral (AAV) vectors expressing Interferon-gamma (IFNγ) were used to induce neuroinflammation in APP/PS1 transgenic mice.
  • Mice were analyzed 4 and 6 months post-injection for IFNγ levels, Aβ burden, and neuroinflammatory markers (microglia, astrocytes).
  • Quantitative PCR and immunohistochemistry were employed to assess neuroinflammatory phenotypes and cellular changes.

Main Results:

  • IFNγ induction led to an M1 neuroinflammatory phenotype at 4 months, which shifted to a mixed phenotype by 6 months.
  • A significant increase in Aβ levels was observed at 6 months post-IFNγ induction.
  • Microglial staining increased, while astrocyte staining decreased at 4 and 6 months in the IFNγ-treated group.

Conclusions:

  • IFNγ-induced M1 phenotype transitions to a mixed phenotype over 6 months in AD mouse models.
  • This phenotypic shift correlates with increased amyloid burden, suggesting a role for mixed or M2-like phenotypes in AD progression.
  • The findings highlight the dynamic nature of neuroinflammation and its complex relationship with amyloid pathology in Alzheimer's disease.

Related Concept Videos